RxDoctor Payments Data

Karma Schmidt

Gerontology · Grand Rapids, MINPI 1548842545

Payments from drug & device makers

$1,081in general payments, 2019–2025

Across 25 payments — averaging $43.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$260
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$202
  • Daiichi Sankyo Inc.$125
  • Medtronic$116
  • Novartis$92
  • Amgen$80
  • plus $207 from 5 others

What the payments were for

  • Food & beverage$1,081100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,081 in reported general payments places this provider in the 65th percentile of 279 gerontology providers in Michigan.

See all gerontology providers in Michigan

Medicare billing

Part B allowed, 2024
$12,458
Medicare patients
122
Services billed
211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban281$356,280
FarxigaDapagliflozin Propanediol94$92,319
XareltoRivaroxaban60$64,138
EntrestoSacubitril/Valsartan59$58,144
JardianceEmpagliflozin27$29,737
Repatha SureclickEvolocumab17$16,117
BrilintaTicagrelor11$13,017
Metoprolol Succinate431$10,464
Dofetilide21$6,201
Atorvastatin Calcium238$4,196
Losartan Potassium136$2,027
Amiodarone Hcl84$1,761
Ezetimibe54$1,754
Carvedilol108$1,725
ClopidogrelClopidogrel Bisulfate79$1,655

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Brilinta$260$105,336105 claims
Johnson & JohnsonXarelto$17$64,13860 claims
NovartisEntresto$92$58,14459 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 279 gerontology providers in Michigan.

Other gerontology in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →